vs
Assertio Holdings, Inc.（ASRT）与FLEXIBLE SOLUTIONS INTERNATIONAL INC（FSI）财务数据对比。点击上方公司名可切换其他公司
Assertio Holdings, Inc.的季度营收约是FLEXIBLE SOLUTIONS INTERNATIONAL INC的1.5倍（$13.5M vs $9.1M），FLEXIBLE SOLUTIONS INTERNATIONAL INC同比增速更快（-0.5% vs -57.9%），过去两年FLEXIBLE SOLUTIONS INTERNATIONAL INC的营收复合增速更高（-0.6% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Flexible Solutions International Inc是一家专注研发生产特种化学品的企业，核心产品包括水体蒸发抑制剂、农作物增产助剂、泳池保温剂等，服务北美及全球农业、水务领域客户。
ASRT vs FSI — 直观对比
营收规模更大
ASRT
是对方的1.5倍
$9.1M
营收增速更快
FSI
高出57.4%
-57.9%
两年增速更快
FSI
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $9.1M |
| 净利润 | — | $-460.9K |
| 毛利率 | — | 29.4% |
| 营业利润率 | -86.7% | 11.6% |
| 净利率 | — | -5.1% |
| 营收同比 | -57.9% | -0.5% |
| 净利润同比 | — | -167.8% |
| 每股收益（稀释后） | $-4.54 | $-0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFSI
| Q4 25 | $13.5M | $9.1M | ||
| Q3 25 | $49.5M | $10.6M | ||
| Q2 25 | $29.2M | $11.4M | ||
| Q1 25 | $26.5M | $7.5M | ||
| Q4 24 | $32.2M | $9.2M | ||
| Q3 24 | $29.2M | $9.3M | ||
| Q2 24 | $31.1M | $10.5M | ||
| Q1 24 | $32.4M | $9.2M |
净利润ASRTFSI
| Q4 25 | — | $-460.9K | ||
| Q3 25 | $11.4M | $-503.4K | ||
| Q2 25 | $-16.4M | $2.0M | ||
| Q1 25 | $-13.5M | $-277.7K | ||
| Q4 24 | — | $679.6K | ||
| Q3 24 | $-2.9M | $611.9K | ||
| Q2 24 | $-3.7M | $1.3M | ||
| Q1 24 | $-4.5M | $457.2K |
毛利率ASRTFSI
| Q4 25 | — | 29.4% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 47.4% | ||
| Q1 25 | — | 26.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 37.4% | ||
| Q1 24 | — | 30.6% |
营业利润率ASRTFSI
| Q4 25 | -86.7% | 11.6% | ||
| Q3 25 | 23.2% | 2.9% | ||
| Q2 25 | -27.5% | 29.0% | ||
| Q1 25 | -50.0% | -0.9% | ||
| Q4 24 | -41.9% | 9.4% | ||
| Q3 24 | -10.4% | 20.5% | ||
| Q2 24 | -11.6% | 18.7% | ||
| Q1 24 | -13.4% | 8.3% |
净利率ASRTFSI
| Q4 25 | — | -5.1% | ||
| Q3 25 | 23.1% | -4.8% | ||
| Q2 25 | -56.0% | 17.8% | ||
| Q1 25 | -51.1% | -3.7% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -10.0% | 6.6% | ||
| Q2 24 | -11.8% | 12.3% | ||
| Q1 24 | -13.9% | 5.0% |
每股收益（稀释后）ASRTFSI
| Q4 25 | $-4.54 | $-0.03 | ||
| Q3 25 | $0.11 | $-0.04 | ||
| Q2 25 | $-0.17 | $0.15 | ||
| Q1 25 | $-0.14 | $-0.02 | ||
| Q4 24 | $-3.28 | $0.05 | ||
| Q3 24 | $-0.03 | $0.05 | ||
| Q2 24 | $-0.04 | $0.10 | ||
| Q1 24 | $-0.05 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | $4.4M |
| 股东权益账面价值 | $94.0M | $38.9M |
| 总资产 | $267.0M | $61.8M |
| 负债/权益比越低杠杆越低 | — | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资ASRTFSI
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | $10.0M | ||
| Q1 25 | $87.3M | $11.0M | ||
| Q4 24 | $100.1M | $10.0M | ||
| Q3 24 | $88.6M | $13.0M | ||
| Q2 24 | $88.4M | $9.2M | ||
| Q1 24 | $80.7M | $8.3M |
总债务ASRTFSI
| Q4 25 | — | $4.4M | ||
| Q3 25 | — | $7.1M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $8.1M | ||
| Q4 24 | — | $8.8M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | $38.6M | $8.0M |
股东权益ASRTFSI
| Q4 25 | $94.0M | $38.9M | ||
| Q3 25 | $105.8M | $39.0M | ||
| Q2 25 | $93.3M | $39.4M | ||
| Q1 25 | $108.5M | $38.4M | ||
| Q4 24 | $121.1M | $38.0M | ||
| Q3 24 | $130.5M | $36.9M | ||
| Q2 24 | $132.2M | $36.2M | ||
| Q1 24 | $134.5M | $36.0M |
总资产ASRTFSI
| Q4 25 | $267.0M | $61.8M | ||
| Q3 25 | $319.8M | $58.4M | ||
| Q2 25 | $273.8M | $58.2M | ||
| Q1 25 | $286.4M | $61.7M | ||
| Q4 24 | $284.7M | $60.0M | ||
| Q3 24 | $276.0M | $57.8M | ||
| Q2 24 | $279.4M | $56.3M | ||
| Q1 24 | $282.0M | $57.6M |
负债/权益比ASRTFSI
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.23× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | 0.29× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-4.0M |
| 自由现金流率自由现金流/营收 | — | -44.3% |
| 资本支出强度资本支出/营收 | — | 11.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-591.7K |
8季度趋势，按日历期对齐
经营现金流ASRTFSI
| Q4 25 | $-30.0M | $-3.0M | ||
| Q3 25 | $-4.8M | $2.0M | ||
| Q2 25 | $19.1M | $5.3M | ||
| Q1 25 | $-12.5M | $-544.3K | ||
| Q4 24 | $11.5M | $-2.2M | ||
| Q3 24 | $-35.0K | $2.5M | ||
| Q2 24 | $7.4M | $5.9M | ||
| Q1 24 | $7.5M | $-604.8K |
自由现金流ASRTFSI
| Q4 25 | — | $-4.0M | ||
| Q3 25 | — | $39.4K | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $-898.4K | ||
| Q4 24 | — | $-4.3M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $4.7M | ||
| Q1 24 | — | $-1.1M |
自由现金流率ASRTFSI
| Q4 25 | — | -44.3% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 37.9% | ||
| Q1 25 | — | -12.0% | ||
| Q4 24 | — | -47.0% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 44.9% | ||
| Q1 24 | — | -11.7% |
资本支出强度ASRTFSI
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | 0.0% | 13.0% | ||
| Q2 24 | — | 11.3% | ||
| Q1 24 | — | 5.2% |
现金转化率ASRTFSI
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | 2.60× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.27× | ||
| Q3 24 | — | 4.05× | ||
| Q2 24 | — | 4.59× | ||
| Q1 24 | — | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FSI
暂无分部数据
